Suicide attempts are more likely to occur in younger, socioeconomically disadvantaged adults.
Computerized cognitive behavioral therapy has been found to be effective at treating patients with depression and anxiety in the primary care setting.
Clinicians must be aware of strategies in order to effectively handle patients receiving these drug regimens.
Among older people with visual impairment, 57.2% are at risk for mild or moderate depression.
Diabetes mellitus (DM) appears to be more prevalent in the psychiatric setting than in the general population.
Researchers found that women who use hormonal contraception have an increased risk for first use of an antidepressant and first diagnosis of depression.
Patients with comorbid bipolar disorder and ADHD may benefit from methylphenidate treatment, if it can be done without incurring the risk of mania.
Intra-subject variability in reaction time (ISVRT) is viewed as a promising behavioral endophenotype for bipolar disorder.
By using the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) questionnaire, investigators accurately predicted bipolar disorder or schizophrenia in more than 85% of patients.
Approximately 80% of depressive episodes have their onset during the first six months following traumatic brain injury.
Pupillary reactivity to emotional stimuli has been investigated to provide objective information about the risk for recurrence of depressive symptoms in women.
Lower diversity of microbial populations in the human gut has been identified in individuals with major depressive disorder.
Findings suggest that in families with 2 generations of direct progenitors with bipolar disorder, an increase in bipolar disorder severity in future generations is likely.
Researchers assessed pain, depression, anxiety, and stress in patients with chronic pain and rheumatoid arthritis.
Treatment initiated in the early stages of bipolar disorder was found more effective than treatment in later stages.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
Researchers investigated the lasting effects of whole body hyperthermia (WBH) in the first randomized, double-blind, [placebo]-controlled study of WBH for the treatment of MDD.
Dysfunction across several cognitive domains is often concomitant with depression.
"Detecting depression in the emergency department is of utmost importance," Dr. Brickman and colleagues wrote in their publication.
The registry contains more than 10,000 EEGs and 38,000 pharmacological outcomes, and is accessible to clinicians worldwide.
Brain-derived Neurotrophic Factor and its Precursor proBDNF as Diagnostic Biomarkers for Mood DisordersSeptember 12, 2016
mBDNF/proBDNF ratio could potentially serve as a novel biomarker for mood disorders.
It is hypothesized that multiple single nucleotide polymorphisms (SNPs) work together to influence risk of complex neuropsychiatric disorders such as depression.
Insights from the Global Burden of Disease Study 2013
The immune system dysregulation may lead to or exacerbate neuropsychiatric conditions such as bipolar disorder.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Minocycline vs Routine Care for Clinical Symptom Improvement in Schizophrenia
- Insomnia in Borderline Personality Disorder May Increase Suicide Risk
- FDA Approves Powerful New Opioid Despite Criticisms
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Psychotropic Medication May Reduce Symptoms and Improve Functioning in PTSD
- Social Decline a Predictor of Conversion Outcome in High-Risk Individuals
- Buprenorphine/Samidorphan Helpful in Refractory Depression